ScholarIQanswers from OpenAlex & ORCID
Mark R. Somerfield
ResearcherPublications, citations & collaboration network
Mark R. Somerfield is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mark R. Somerfield have?
ScholarIQindexed works
Mark R. Somerfield has 183 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mark R. Somerfield have?
ScholarIQcitation count
Mark R. Somerfield has 42,578 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mark R. Somerfield?
ScholarIQh-index
Mark R. Somerfield has an h-index of 82 in OpenAlex.
What is the i10-index of Mark R. Somerfield?
ScholarIQi10-index
Mark R. Somerfield has an i10-index of 132 in OpenAlex.
What is the ORCID of Mark R. Somerfield?
ScholarIQorcid
The ORCID for Mark R. Somerfield is on the source record.
What is the OpenAlex record for Mark R. Somerfield?
ScholarIQopenalex
The OpenAlex for Mark R. Somerfield is on the source record.
What are the most-cited papers on Mark R. Somerfield?
ScholarIQmost cited works
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
Lyndsay N. Harris, Herbert A. Fritsche, Robert Mennel, Larry Norton, Peter M. Ravdin, Sheila E. Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Gary H. Lyman, Armando E. Giuliano, Mark R. Somerfield, Al B. Benson, Diane C. Bodurka, Harold J. Burstein, Alistair J. Cochran, Hiram S. Cody, Stephen B. Edge, Sharon Galper, James A. Hayman, Theodore Y. Kim, Cheryl Perkins, Donald A. Podoloff, Visa Haran Sivasubramaniam, Roderick R. Turner, Richard L. Wahl, Donald L. Weaver, Antonio C. Wolff, Eric P. Winer
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
Thomas J. Smith, James Khatcheressian, Gary H. Lyman, Howard Ozer, Jamés O. Armitage, Lodovico Balducci, Charles L. Bennett, Scott B. Cantor, Jeffrey Crawford, Scott J. Cross, George D. Demetri, Christopher E. Desch, Philip A. Pizzo, Charles A. Schiffer, Lee S. Schwartzberg, Mark R. Somerfield, George Somlo, James C. Wade, James L. Wade, Rodger J. Winn, Antoinette J. Wozniak, Antonio C. Wolff
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
Supriya G. Mohile, William Dale, Mark R. Somerfield, Mara A. Schonberg, Cynthia M. Boyd, Peggy Burhenn, Beverly Canin, Harvey Jay Cohen, Holly M. Holmes, Judith O. Hopkins, Michelle C. Janelsins, Alok A. Khorana, Heidi D. Klepin, Stuart M. Lichtman, Karen M. Mustian, William P. Tew, Arti Hurria
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
David G. Pfister, David H. Johnson, Christopher G. Azzoli, William T. Sause, Thomas J. Smith, Sherman Baker, Jemi Olak, Diane E. Stover, John R. Strawn, Andrew T. Turrisi, Mark R. Somerfield